Access Financial Services, Inc. Amgen Inc Transaction History

Access Financial Services, Inc.

  • $184 Million
  • Q3 2024

A detailed history of Access Financial Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Access Financial Services, Inc. holds 3,576 shares of AMGN stock, worth $944,064. This represents 0.62% of its overall portfolio holdings.

Number of Shares
3,576
Previous 3,587 0.31%
Holding current value
$944,064
Previous $1.12 Million 2.86%
% of portfolio
0.62%
Previous 0.59%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
SELL
$309.38 - $337.38 $3,403 - $3,711
-11 Reduced 0.31%
3,576 $1.15 Million
Q2 2024

Jul 25, 2024
SELL
$262.75 - $319.31 $218,870 - $265,985
-833 Reduced 18.85%
3,587 $1.12 Million
Q1 2024

Apr 22, 2024
BUY
$268.87 - $324.56 $46,783 - $56,473
174 Added 4.1%
4,420 $1.26 Million
Q4 2023

Jan 18, 2024
SELL
$255.7 - $288.46 $202,003 - $227,883
-790 Reduced 15.69%
4,246 $1.22 Million
Q3 2023

Oct 25, 2023
BUY
$218.65 - $271.46 $181,916 - $225,854
832 Added 19.79%
5,036 $1.35 Million
Q2 2023

Aug 07, 2023
SELL
$214.27 - $253.37 $7,285 - $8,614
-34 Reduced 0.8%
4,204 $933,000
Q1 2023

Apr 21, 2023
BUY
$225.79 - $275.2 $107,701 - $131,270
477 Added 12.68%
4,238 $1.02 Million
Q4 2022

Jan 19, 2023
SELL
$229.03 - $291.01 $328,429 - $417,308
-1,434 Reduced 27.6%
3,761 $0
Q3 2022

Oct 18, 2022
SELL
$224.46 - $253.15 $4,489 - $5,063
-20 Reduced 0.38%
5,195 $1.17 Million
Q2 2022

Jul 20, 2022
SELL
$230.71 - $256.74 $329,684 - $366,881
-1,429 Reduced 21.51%
5,215 $1.27 Million
Q1 2022

Apr 19, 2022
SELL
$219.27 - $242.57 $339,868 - $375,983
-1,550 Reduced 18.92%
6,644 $1.61 Million
Q4 2021

Jan 14, 2022
SELL
$198.88 - $227.6 $42,560 - $48,706
-214 Reduced 2.55%
8,194 $1.84 Million
Q3 2021

Oct 28, 2021
SELL
$212.27 - $248.7 $7,641 - $8,953
-36 Reduced 0.43%
8,408 $1.79 Million
Q2 2021

Jul 15, 2021
SELL
$233.58 - $259.14 $380,501 - $422,139
-1,629 Reduced 16.17%
8,444 $2.06 Million
Q1 2021

Apr 23, 2021
SELL
$221.91 - $258.6 $24,632 - $28,704
-111 Reduced 1.09%
10,073 $2.51 Million
Q4 2020

Jan 14, 2021
BUY
$216.38 - $257.67 $21,421 - $25,509
99 Added 0.98%
10,184 $2.34 Million
Q3 2020

Nov 09, 2020
SELL
$234.65 - $260.95 $30,739 - $34,184
-131 Reduced 1.28%
10,085 $2.56 Million
Q2 2020

Aug 11, 2020
BUY
$197.81 - $242.74 $355,860 - $436,689
1,799 Added 21.37%
10,216 $2.41 Million
Q1 2020

Apr 16, 2020
SELL
$182.24 - $241.7 $22,233 - $29,487
-122 Reduced 1.43%
8,417 $1.71 Million
Q4 2019

Jan 21, 2020
SELL
$189.21 - $243.2 $4,541 - $5,836
-24 Reduced 0.28%
8,539 $2.06 Million
Q3 2019

Nov 01, 2019
BUY
$174.11 - $208.62 $35,692 - $42,767
205 Added 2.45%
8,563 $1.66 Million
Q2 2019

Jul 24, 2019
BUY
$166.7 - $195.41 $140,861 - $165,121
845 Added 11.25%
8,358 $1.54 Million
Q1 2019

Apr 26, 2019
BUY
$180.87 - $203.88 $809,393 - $912,363
4,475 Added 147.3%
7,513 $1.43 Million
Q4 2018

Feb 19, 2019
BUY
$178.4 - $208.25 $7,136 - $8,330
40 Added 1.33%
3,038 $591,000
Q3 2018

Oct 26, 2018
BUY
$185.29 - $208.89 $1,667 - $1,880
9 Added 0.3%
2,998 $621,000
Q2 2018

Jul 20, 2018
BUY
$166.05 - $186.51 $80,866 - $90,830
487 Added 19.46%
2,989 $552,000
Q1 2018

Apr 27, 2018
BUY
$169.43 - $198.0 $16,095 - $18,810
95 Added 3.95%
2,502 $427,000
Q4 2017

Jan 16, 2018
BUY
$168.79 - $188.59 $161,025 - $179,914
954 Added 65.66%
2,407 $419,000
Q3 2017

Nov 02, 2017
BUY
$167.29 - $191.0 $243,072 - $277,523
1,453
1,453 $271,000

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Access Financial Services, Inc. Portfolio

Follow Access Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Access Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Access Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email